Waldenstrom’s macroglobulinaemia - Articles and news items

NICE does not recommend Janssen’s Waldenstrom’s macroglobulinaemia candidate

Industry news / 17 October 2016 / Niamh Louise Marriott, Digital Content Producer

NICE has published draft guidance that does not recommend Janssen’s Imbruvica (ibrutinib) for treating some people with Waldenstrom’s macroglobulinaemia…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+